At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 100 enrolled
Drug / intervention
Colchicine 0.6 mg +1 moredrug
Likely dose
Colchicine 0.6 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Colchicine For Prevention of Perioperative Atrial Fibrillation in Patients Undergoing Thoracic Surgery Pilot Study.
In Brief
A Phase 3 clinical trial evaluating Colchicine 0.6 mg and Placebo Colchicine for Atrial Fibrillation and Thoracic Surgery. Completed, enrolled 100 participants across 2 sites.
Detailed Summary
The purpose of this pilot study is to determine the feasibility of comparing colchicine to placebo for the prevention of new onset atrial fibrillation in patients undergoing general thoracic surgery and establish the foundation for a large, multi-centre, clinical trial.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtrial Fibrillation, Thoracic Surgery
CountriesCanada
CollaboratorsCanadian Institutes of Health Research (CIHR)
Timeline
Phase 3CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedNov 2013
Enrollment StartApr 2014
Primary CompletionApr 2015
Study CompletionSep 2015
TodayJul 2026
First PostedNov 15, 2013
Enrollment StartApr 1, 2014
Primary CompletionApr 1, 2015
Study CompletionSep 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 12.6 years ago
Interventions
Colchicine 0.6 mgdrug
Placebo Colchicinedrug